ROSsELLA MEDORI
Chief Medical/Scientific Officer
Owner and founder, TriMED Healthcare Consulting, Switzerland
Vice President, Clinical Development, Biogen, Switzerland
Vice President, Late Stage Development, Biogen, Switzerland
Vice President, Translational Medicine, Biogen, Switzerland
Chief Medical Officer, Eidetica (Biogen spin-off), Switzerland
Global Clinical Director and European Medical Director, Psychiatry, Janssen Cilag EMEA
European Brand Leader, Neuroscience Medical Director, Bristol-Myers Squibb Germany
Clinical Research Physician, CNS, Eli Lilly, Germany
Consultant, Preclinical and Clinical Research, Fidia Research Laboratory, Italy
Assistant Professor of Neurology, Columbia University Medical Center, Presbyterian Hospital, New York
M.D., Residency Neurology, Bologna University, School of Medicine, Italy
USA: ECFMG license n. 395-840-2
USA medical licensing: Federation Licensing Examination (FLEX) New York State
Post-doctoral fellowships: Case Western Reserve University and Washington University.
Italian
Italian, English, German
............................................................................................................
............................................................................................................
............................................................................................................
..............................................................................
..............................................................................
..............................................................................
..............................................................................
..............................................................................
.................................................................................................
.................................................................................................
.................................................................................................
.................................................................................................
.................................................................................................
...................................................................................
...................................................................................
...................................................................................
...................................................................................
.....................................................................
.....................................................................
.....................................................................
.....................................................................
.....................................................................
© 2018 Vicarius Pharma AG